Evidence map›Paper›PMID 41597266›Full record

ArticleCells2026

TRPA1 as a Key Regulator of Keratinocyte Homeostasis and Inflammation in Human Skin.

Caterina Cattani, Claudia Scarponi, Martina Morelli, Kilian Eyerich, Stefanie Eyerich, Christian Napoli, Stefania Madonna, Cristina Albanesi, Andrea Cavani, Fernanda Scopelliti

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Caterina CattaniNational Institute for Health, Migration and Poverty INMP/NIHMP, via di S. Gallicano, 25, 00153 Rome, Italy.
Claudia ScarponiLaboratory of Experimental Immunology, Isituto Dermatopatico Italiano IDI-IRCCS, via Monti di Creta, 04, 00167 Rome, Italy.ORCID 0000-0002-2323-8519
Martina MorelliLaboratory of Experimental Immunology, Isituto Dermatopatico Italiano IDI-IRCCS, via Monti di Creta, 04, 00167 Rome, Italy.
Kilian EyerichClinic of Dermatology and Venereology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0003-0094-2674
Stefanie EyerichClinic of Dermatology and Venereology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Christian NapoliNational Institute for Health, Migration and Poverty INMP/NIHMP, via di S. Gallicano, 25, 00153 Rome, Italy.
Stefania MadonnaLaboratory of Experimental Immunology, Isituto Dermatopatico Italiano IDI-IRCCS, via Monti di Creta, 04, 00167 Rome, Italy.ORCID 0000-0003-0585-6783
Cristina AlbanesiLaboratory of Experimental Immunology, Isituto Dermatopatico Italiano IDI-IRCCS, via Monti di Creta, 04, 00167 Rome, Italy.ORCID 0000-0002-7537-6833
Andrea CavaniNational Institute for Health, Migration and Poverty INMP/NIHMP, via di S. Gallicano, 25, 00153 Rome, Italy.
Fernanda ScopellitiNational Institute for Health, Migration and Poverty INMP/NIHMP, via di S. Gallicano, 25, 00153 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Transient Receptor Potential Ankyrin 1 (TRPA1) channel is a non-selective cation channel activated by a range of physical and chemical stimuli. While primarily studied in neuronal tissues, TRPA1 is also expressed in human keratinocytes, where its role remains poorly understood. Here, we investigated TRPA1 expression and function in keratinocytes and examined the effects of its activation on cellular proliferation, immune activation, and neuropeptide release under both basal and inflammatory stimuli. TRPA1 expression was detected in basal keratinocytes and was upregulated by pro-inflammatory cytokines. Stimulation with the TRPA1 agonist allyl isothiocyanate (AITC) induced a rapid calcium influx, confirming functional channel activity. AITC at 5 µM did not induce cytotoxicity but significantly reduced keratinocyte proliferation and caused cell cycle arrest. Under stimulation with TNF-α and IFN-γ, TRPA1 activation decreased the surface expression of HLA-DR and ICAM-1, and downregulated mRNA levels of CXCL10, CXCL8, CCL5, and CCL20, while IL-6 expression remained unchanged. Furthermore, AITC treatment reduced the secretion of Substance P, but not CGRP. These findings indicate that TRPA1 functions as a cytokine-inducible, immunomodulatory receptor in human keratinocytes, capable of attenuating proliferation and inflammatory activation without compromising cell viability, thereby suggesting a potential role in maintaining skin homeostasis and modulating cutaneous inflammation.

Indexed as

HomeostasisInflammationKeratinocytesSkinTRPA1 Cation ChannelCalciumCell ProliferationCytokinesHumansIsothiocyanatesallyl isothiocyanateCalciumCytokinesIsothiocyanatesTRPA1 Cation ChannelTRPA1 protein, humankeratinocytesskintransient receptorsTRP

Identifiers

PMID41597266
PMCPMC12840384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.